Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorKyungpook National University Hospital

About this trial

The aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who have positive results in PCR or culture of rectal swab.

Disqualifiers

Not provide a consent.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Fecal Microbial transplant Capsules

    Combination product

    3 pills per day for 3 consecutive days with placebo comparatator

  • Placebo

    Combination product

    The same amount and shape capsules

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Fecal microbiota transplantation groupActive comparator 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Conversion to negative organism

Time frame
1 year

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: